160 related articles for article (PubMed ID: 25234162)
1. The association between the APE1 Asp148Glu polymorphism and prostate cancer susceptibility: a meta-analysis based on case-control studies.
Zhou X; Wei L; Jiao G; Gao W; Ying M; Wang N; Wang Y; Liu C
Mol Genet Genomics; 2015 Feb; 290(1):281-8. PubMed ID: 25234162
[TBL] [Abstract][Full Text] [Related]
2. The association between the APE1 Asp148Glu polymorphism and breast cancer susceptibility: a meta-analysis based on case-control studies.
Zhao Z; Liu C; Zeng Y; Gu L; Ying M; Wang N; Hao B; Yao H; Su C; Wang Y; Ma Y
Tumour Biol; 2014 May; 35(5):4727-34. PubMed ID: 24414702
[TBL] [Abstract][Full Text] [Related]
3. Association between APE1 T1349G polymorphism and prostate cancer risk: evidence from a meta-analysis.
Li X; Zhang G; Huai YJ; Cao ZQ
Tumour Biol; 2014 Oct; 35(10):10111-9. PubMed ID: 25023401
[TBL] [Abstract][Full Text] [Related]
4. Relationship between apurinic endonuclease 1 Asp148Glu polymorphism and gastrointestinal cancer risk: An updated meta-analysis.
Dai ZJ; Shao YP; Kang HF; Tang W; Xu D; Zhao Y; Liu D; Wang M; Yang PT; Wang XJ
World J Gastroenterol; 2015 Apr; 21(16):5081-9. PubMed ID: 25945024
[TBL] [Abstract][Full Text] [Related]
5. The APE1 Asp148Glu polymorphism and colorectal cancer susceptibility: a meta-analysis.
Shen E; Liu C; Wei L; Hu J; Weng J; Yin Q; Wang Y
Tumour Biol; 2014 Mar; 35(3):2529-35. PubMed ID: 24254302
[TBL] [Abstract][Full Text] [Related]
6. Association between APE1 ASP148GLU and colorectal cancer risk: A meta-analysis.
Lin C; Jin Y; Cheng S; Wang W
Clin Invest Med; 2020 Dec; 43(4):E24-34. PubMed ID: 33370522
[TBL] [Abstract][Full Text] [Related]
7. APE1 Asp148Glu gene polymorphism and bladder cancer risk: a meta-analysis.
Liu C; Yin Q; Li L; Zhuang YZ; Zu X; Wang Y
Mol Biol Rep; 2013 Jan; 40(1):171-6. PubMed ID: 23143180
[TBL] [Abstract][Full Text] [Related]
8. Association between apurinic/apyrimidinic endonuclease 1 rs1760944 T>G polymorphism and susceptibility of cancer: a meta-analysis involving 21764 subjects.
Ding G; Chen Y; Pan H; Qiu H; Tang W; Chen S
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31804681
[TBL] [Abstract][Full Text] [Related]
9. Association between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis.
Wei W; He XF; Qin JB; Su J; Li SX; Liu Y; Zhang Y; Wang W
Mol Biol Rep; 2012 Dec; 39(12):11249-62. PubMed ID: 23065211
[TBL] [Abstract][Full Text] [Related]
10. APE1 Asp148Glu gene polymorphism and lung cancer risk: a meta-analysis.
Ji YN; Zhan P; Wang J; Qiu LX; Yu LK
Mol Biol Rep; 2011 Oct; 38(7):4537-43. PubMed ID: 21132382
[TBL] [Abstract][Full Text] [Related]
11. The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies.
Gu D; Wang M; Wang M; Zhang Z; Chen J
Mutagenesis; 2009 Nov; 24(6):507-12. PubMed ID: 19762350
[TBL] [Abstract][Full Text] [Related]
12. APE1 Asp148Glu polymorphism and lung cancer susceptibility.
Cai L; Fu Y; Zhang Y
Tumour Biol; 2014 Jun; 35(6):5237-44. PubMed ID: 24523018
[TBL] [Abstract][Full Text] [Related]
13. The association between 1349T>G polymorphism of ApE1 gene and the risk of prostate cancer in northern Iran.
Pournourali M; Tarang AR; Yousefi M
Cell Mol Biol (Noisy-le-grand); 2015 Aug; 61(4):21-4. PubMed ID: 26255264
[TBL] [Abstract][Full Text] [Related]
14. Lack of an association between two BER gene polymorphisms and breast cancer risk: a meta-analysis.
Wu B; Liu HL; Zhang S; Dong XR; Wu G
PLoS One; 2012; 7(12):e50857. PubMed ID: 23272074
[TBL] [Abstract][Full Text] [Related]
15. Association between APE1 rs1760944 and rs1130409 polymorphism with prostate cancer risk: A systematic review and meta-analysis.
Liu J; Zheng J; Guo Y; Sheng X; Yin Y; Qian S; Xu B; Xiong W; Yin X
Medicine (Baltimore); 2021 Nov; 100(46):e27630. PubMed ID: 34797286
[TBL] [Abstract][Full Text] [Related]
16. Apurinic/apyrimidinic endonuclease 1 polymorphisms are associated with ovarian cancer susceptibility in a Chinese population.
Zhang X; Xin X; Zhang J; Li J; Chen B; Zou W
Int J Gynecol Cancer; 2013 Oct; 23(8):1393-9. PubMed ID: 24257553
[TBL] [Abstract][Full Text] [Related]
17. The association of APE1 -656T > G and 1349 T > G polymorphisms and cancer risk: a meta-analysis based on 37 case-control studies.
Zhou B; Shan H; Su Y; Xia K; Shao X; Mao W; Shao Q
BMC Cancer; 2011 Dec; 11():521. PubMed ID: 22176746
[TBL] [Abstract][Full Text] [Related]
18. Association between the APEX1 Asp148Glu polymorphism and prostate cancer, especially among Asians: a new evidence-based analysis.
Chen Y; Li J; Mo Z
Oncotarget; 2016 Aug; 7(32):52530-52540. PubMed ID: 27248666
[TBL] [Abstract][Full Text] [Related]
19. Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis.
Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
Diagn Pathol; 2014 Jun; 9():108. PubMed ID: 24893568
[TBL] [Abstract][Full Text] [Related]
20. A genetic variant in the promoter of APE1 gene (-656 T>G) is associated with breast cancer risk and progression in a Chinese population.
Kang H; Dai Z; Ma X; Ma L; Jin Y; Liu X; Wang X
Gene; 2013 Nov; 531(1):97-100. PubMed ID: 23994194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
